Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus

Journal of Viral Hepatitis

Volumn 13, Issue 3, 2006, Pages 177-181

  Rios M ^a,c   Diago, M ^a   Rivera, P ^a   Tuset, C ^b   Cors, R ^a   Garcia V ^a   Carbonel, P ^a   Gonzalez, C ^a  

^a Service of Digestive Diseases   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c NONE   (Spain)

Author keywords

Anti HCV antibodies; Blood donors; Indeterminate RIBA 3

Indexed keywords

AMINOTRANSFERASE; HEPATITIS C ANTIBODY;

ADULT; AGE DISTRIBUTION; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHRONIC ACTIVE HEPATITIS; CHRONIC HEPATITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ABUSE; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PUNCTURE; RISK FACTOR; SEX RATIO; STATISTICAL ANALYSIS; SURGICAL PATIENT; TATTOO; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGE FACTORS; ALANINE TRANSAMINASE; BLOOD DONORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; IMMUNOBLOTTING; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RISK FACTORS; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES;

EID: 33645098317     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00673.x     Document Type: Article

References (31)

1. Colin C Lanoir D Touzet S Meyaud-Kraemer L Bailly F Trepo C Hepatitis Group. Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature J Viral Hepat 2001 8 2 87 95
2. Centers for Disease Control and Prevention Recommendations for the prevention and control of hepatitis C virus infection and HCV-related chronic disease MMWR 1998 47 No. RR-19 1 33
3. Evensoy S Diagnosis of hepatitis C virus infection and laboratory monitoring of its therapy J Clin Virol 2001 21 3 271 281
4. Richter SS Laboratory assays for the diagnosis and management of hepatitis C virus infection J Clin Microbiol 2002 40 12 4407 4412
5. Tobler LH Lee SR Stramer SL et al. Performance of second and third-generation RIBAs for confirmation of third-generation HCV EIA-reactive blood donations Transfusion 2000 40 917 923
6. Schroter M Schafer P Zollner B et al. Strategies for reliable diagnosis of hepatitis C infection: the need for a serological confirmatory assay J Med Virol 2001 64 320 324
7. Pawlotsky JM Lonjon I Hezode C et al. What strategy should be used for the diagnosis of hepatitis C virus infection in clinical laboratories Hepatology 1998 27 1700 1702
8. Pawlotsky JM Use and interpretation of virological tests for hepatitis C Hepatology 2002 36 s65 s73
9. Alter MJ Kruszon-Moran D Nainan OV et al. Prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 1999 341 556 562
10. Conry-Cantinela C Van Raden M Gibble J et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection N Engl J Med 1996 334 1691 1696
11. Sakugawa H Nakasone H Nakayoshi T et al. High proportion of false positive reactions among donors with anti-HCV antibodies in a low prevalence area J Med Virol 1995 46 334 338
12. Bar-Shany S Green MS Shinar E False positive tests for anti-hepatitis C antibodies and the problem of notifying blood donors Int J Epidemiol 1996 25 674 678
13. Centers for Disease Control and Prevention Guidelines for Laboratory Testing and Result Reporting of Antibody to Hepatitis C Virus in Centers for Disease Control and Prevention MMWR Recomm. Rep. 2003 52 RR-3 1 13,15 quiz CE1-4
14. Kiely P Eliades L Kebede M Stephenson M Jardine D Anti-HCV confirmatory testing of voluntary blood donors: comparison of the sensitivity of two immunoblot assays Transfusion 2002 42 8 1053 1058
15. Pawlotsky JM Bastie A Pellet C et al. Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay J Clin Microbiol 1996 34 80 83
16. Leon P Lopez JA Elola C et al. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen Vox Sang 1998 75 1 32 36
17. Kitchen AD Tucker NV The specificity of anti-HCV supplementary assays Vox Sang 1995 69 100 103
18. Kanistanon D Neelamek M Dharakul T Songsivilai S The immunoreactivity profile of different HCV genotypes on immunoblot assay and its implications in the development of diagnostic assays Asian Pacific J Allergy Immunol 1997 15 133 140
19. Halfon P Bourliere M Khiri H et al. Serological response to infection with different isolates of hepatitis C virus J Viral Hepat 2002 9 438 442
20. Ferroni P Tagger A Pasquali M et al. What are the consequences of indeterminate results in confirmatory tests for antibodies against transmissible viruses Vox Sang 1997 73 97 104
21. Wu Y Schreiber GB Busch MP et al. Donor behavior after notification of abnormal laboratory test results (abstract) Transfusion 1999 39 Suppl. 113s
22. Kleinman SH Williams AE Busch MP Wu Y Donor reactions to notification of abnormal test results (abstract) Transfusion 1000 39 Suppl. 113s
23. Leon P Lopez JA Elola C et al. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV Vox Sang 1996 70 32 36
24. Kiely P Deborah K Parker S Piscitelli L The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays Transfusion 2004 44 349 358
25. Desmet VJ Histological classification of chronic hepatitis Acta Gastroenterol Belg 1997 60 4 259 267
26. Vernelen K Claeys H Verhaert AH Volckaerts A Vermylen C Significance of NS3 and NS5 antigens in screening for HCV antibody Lancet 1994 343 853
27. Damen M Zaaijer HL Cuypers HT et al. Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus Transfusion 1995 35 745 749
28. Craxi A Valenza M Fabiano C et al. Third-generation hepatitis C virus tests in asymptomatic anti-HCV-positive blood donors J Hepatol 1994 21 5 730 734
29. Iacono L DeCastro M Garcia-Buey L et al. Epidemiological risk factors and clinico-pathological presentation in chronic hepatitis C Hepatogastroenterology 1998 45 23 1715 1721
30. Lamoril J Lunel F Laurent-Puig P et al. Indeterminate third-generation recombinant immunoblot assay in hepatitis C virus infection. Group d'Etudes Moleculaires des Hepatites (GEMHEP) J Hepatol 1994 21 1 133 134
31. Puoti C Magrini A Stati T et al. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels Hepatol 1997 Vol. 26 no. 6 1393 1398